Medicine
Is $2.1 Million Too Much for a Drug? For Affected Parents, There Is No Debate
Similarly effective drugs in the pipeline will also be gauged against their enormous price tags
Stories by Damian Garde
Policy & Ethics
Former CDC Director Tom Frieden Arrested on Sexual Misconduct Charge
The alleged incident occurred in October
Neuroscience
Alzheimer's Study Sparks a New Round of Debate over the Amyloid Hypothesis
Does the data in a recent clinical trial support the idea that removing amyloid clumps can improve mental functioning?
Medicine
Experimental Alzheimer’s Drug Significantly Slowed Patients’ Cognitive Decline
The surprising results have buoyed hopes for treatment
Policy & Ethics
7 Questions to Watch in the Theranos Saga
Since criminal charges were filed, these may be the most pressing issues
Medicine
Amgen's New Migraine Drug Will Cost 30 Percent Less Than Wall Street Expected
Clinical trial patients had two fewer headaches a month compared with those who received a placebo
Medicine
The Most Expensive U.S. Medicine Now Has an Official Sticker Price
This gene therapy for vision loss will initially cost $850,000
Medicine
FDA Approves Second CAR-T Treatment for Cancer
The pricey therapy is designed for adults with advanced lymphoma
Biotech
FDA Green-Lights First CAR-T Cancer Drug
The leukemia treatment approval opens up a new front for gene therapies in the U.S.
Biotech
Novel Gene Therapy for Leukemia Clears FDA Panel
The experimental treatment will now face review by the agency
Policy & Ethics
Top Academics Lash Out at Trump's "Un-American" Immigration Order
Scientists from all over the country are calling for an end to a immigration ban that could potentially affect thousands of scientists working in the U.S.
Neuroscience
Hopes Dashed as Alzheimer’s Drug Fails in Late-Stage Trial
The result could be a major setback for the strategy of attacking amyloid plaques
Policy & Ethics
5 Ways Trump's Win Can Change Medicine and Science
Priorities at the NIH, the BRAIN Initiative, drug price controls and more initiatives could shift in major ways
Biotech
A Possible Cure for "Bubble Boy" Disease Will Cost $665,000--Per Dose
The gene therapy could save kids with severe combined immune deficiency
Medicine
FDA Lets Cancer Trial Resume after 3 Patient Deaths
Standard chemo blamed, experimental immune therapy cleared
Biotech
3 Patient Deaths Halt Promising Cancer Therapy Test
An immune system booster called CAR-T appears to cause lethal brain injury
Biology
Could a Molecular "On/Off Agony" Switch Make Painkillers Safer?
As opioid addiction soars, biotech companies eye a genetic mutation in people who feel no pain
